Taro Pharmaceuticals North America, Inc. c/o Taro Pharmaceuticals U.S.A., Inc.

Patent application number	Title	Published
Taro Pharmaceuticals North America, Inc. c/o Taro Pharmaceuticals U.S.A., Inc. Patent applications
20090131538	Novel propofol composition comprising a pharmaceutically acceptable salt of formaldehyde sulfoxylate - Sterile pharmaceutical compositions for parenteral administration containing 2,6-diisopropylphenol (propofol) are described for use as anesthetics. The compositions comprise an oil-in-water emulsion of propofol additionally comprising an amount of a pharmaceutically acceptable salt of formaldehyde sulfoxylate sufficient to prevent significant growth of microorganisms for at least 24 hours after adventitious contamination.	05-21-2009